Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth

Cell Reports

Volumn 15, Issue 12, 2016, Pages 2679-2691

  Rowald, Konstantina ^a   Mantovan, Martina ^a   Passos, Joana ^a   Buccitelli, Christopher ^b   Mardin, Balca R ^b   Korbel, Jan O ^b   Jechlinger, Martin ^a   Sotillo, Rocio ^a,c  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MAD2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; KRAS2 PROTEIN, MOUSE; PROTEIN P21;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL DEATH; CELL METABOLISM; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE OVEREXPRESSION; GENETIC VARIABILITY; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MAMMARY GLAND; MITOSIS; MITOSIS INHIBITION; MOLECULAR CLONING; MORPHOLOGY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; TRANSGENE; ANEUPLOIDY; ANIMAL; APOPTOSIS; BREAST TUMOR; CELL CULTURE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHROMOSOME SEGREGATION; EPITHELIUM CELL; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE; SPINDLE APPARATUS; TIME LAPSE IMAGING;

ANEUPLOIDY; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CARCINOGENESIS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAD2 PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MITOSIS; ONCOGENES; PHENOTYPE; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, ERBB-2; SPINDLE APPARATUS; TIME-LAPSE IMAGING; TRANSGENES;

EID: 84975124878     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.048     Document Type: Article

References (52)

1. Boveri T. ANTON DOHBN. Science 1912, 36:453-468.
2. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 2006, 38:1043-1048.
3. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404.
4. Chen G., Rubinstein B., Li R. Whole chromosome aneuploidy: big mutations drive adaptation by phenotypic leap. BioEssays 2012, 34:893-900.
5. Chen G., Mulla W.A., Kucharavy A., Tsai H.-J., Rubinstein B., Conkright J., McCroskey S., Bradford W.D., Weems L., Haug J.S., et al. Targeting the adaptability of heterogeneous aneuploids. Cell 2015, 160:771-784.
6. Denning D.P., Hatch V., Horvitz H.R. Programmed elimination of cells by caspase-independent cell extrusion in C. elegans. Nature 2012, 488:226-230.
7. Duijf P.H.G., Benezra R. The cancer biology of whole-chromosome instability. Oncogene 2013, 32:4727-4736.
8. Endesfelder D., Burrell R.A., Kanu N., McGranahan N., Howell M., Parker P.J., Downward J., Swanton C., Kschischo M. Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer. Cancer Res. 2014, 74:4853-4863.
9. Fata J.E., Chaudhary V., Khokha R. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol. Reprod. 2001, 65:680-688.
10. Fisher G.H., Wellen S.L., Klimstra D., Lenczowski J.M., Tichelaar J.W., Lizak M.J., Whitsett J.A., Koretsky A., Varmus H.E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 2001, 15:3249-3262.
11. Gao J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., Sun Y., Jacobsen A., Sinha R., Larsson E., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013, 6:l1.
12. Gilmore A.P. Anoikis. Cell Death Differ. 2005, 12(Suppl 2):1473-1477.
13. Gunther E.J., Belka G.K., Wertheim G.B.W., Wang J., Hartman J.L., Boxer R.B., Chodosh L.A. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 2002, 16:283-292.
14. Habermann J.K., Doering J., Hautaniemi S., Roblick U.J., Bündgen N.K., Nicorici D., Kronenwett U., Rathnagiriswaran S., Mettu R.K.R., Ma Y., et al. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int. J. Cancer 2009, 124:1552-1564.
15. Hadjantonakis A.-K., Papaioannou V.E. Dynamic in vivo imaging and cell tracking using a histone fluorescent protein fusion in mice. BMC Biotechnol. 2004, 4:33.
16. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
17. Jamal-Hanjani M., A'Hern R., Birkbak N.J., Gorman P., Grönroos E., Ngang S., Nicola P., Rahman L., Thanopoulou E., Kelly G., et al. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial. Ann. Oncol. 2015, 26:1340-1346.
18. Janssen A., Medema R.H. Genetic instability: tipping the balance. Oncogene 2013, 32:4459-4470.
19. Jechlinger M., Podsypanina K., Varmus H. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. Genes Dev. 2009, 23:1677-1688.
20. Kabeche L., Compton D.A. Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr. Biol. 2012, 22:638-644.
21. Laughney A.M., Elizalde S., Genovese G., Bakhoum S.F. Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution. Cell Rep. 2015, 12:809-820.
22. Lee A.J.X., Endesfelder D., Rowan A.J., Walther A., Birkbak N.J., Futreal P.A., Downward J., Szallasi Z., Tomlinson I.P.M., Howell M., et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 2011, 71:1858-1870.
23. Leung J.Y., Andrechek E.R., Cardiff R.D., Nevins J.R. Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene 2012, 31:2545-2554.
24. Li M., Fang X., Baker D.J., Guo L., Gao X., Wei Z., Han S., van Deursen J.M., Zhang P. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc. Natl. Acad. Sci. USA 2010, 107:14188-14193.
25. Mardin B.R., Drainas A.P., Waszak S.M., Weischenfeldt J., Isokane M., Stütz A.M., Raeder B., Efthymiopoulos T., Buccitelli C., Segura-Wang M., et al. A cell-based model system links chromothripsis with hyperploidy. Mol. Syst. Biol. 2015, 11:828.
26. McCormack S.J., Weaver Z., Deming S., Natarajan G., Torri J., Johnson M.D., Liyanage M., Ried T., Dickson R.B. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 1998, 16:2755-2766.
27. Moasser M.M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007, 26:6469-6487.
28. Montagna C., Andrechek E.R., Padilla-Nash H., Muller W.J., Ried T. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene 2002, 21:890-898.
29. Moody S.E., Sarkisian C.J., Hahn K.T., Gunther E.J., Pickup S., Dugan K.D., Innocent N., Cardiff R.D., Schnall M.D., Chodosh L.A. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2002, 2:451-461.
30. Pérez de Castro I., Aguirre-Portolés C., Fernández-Miranda G., Cañamero M., Cowley D.O., Van Dyke T., Malumbres M. Requirements for Aurora-A in tissue regeneration and tumor development in adult mammals. Cancer Res. 2013, 73:6804-6815.
31. Podsypanina K., Politi K., Beverly L.J., Varmus H.E. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc. Natl. Acad. Sci. USA 2008, 105:5242-5247.
32. Pylayeva-Gupta Y., Grabocka E., Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 2011, 11:761-774.
33. Radisky D. On the role of the microenvironment in mammary gland development and cancer. Cold Spring Harb. Perspect. Biol. 2012, 4:a013458.
34. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
35. Rosenblatt J., Raff M.C., Cramer L.P. An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism. Curr. Biol. 2001, 11:1847-1857.
36. Rudmann D., Cardiff R., Chouinard L., Goodman D., Küttler K., Marxfeld H., Molinolo A., Treumann S., Yoshizawa K. Proliferative and nonproliferative lesions of the rat and mouse mammary, Zymbal's, preputial, and clitoral glands. Toxicol. Pathol. 2012, 40(6, Suppl):7S-39S. INHAND Mammary, Zymbal's, Preputial, and Clitoral Gland Organ Working Group.
37. Sanchez-Garcia F., Villagrasa P., Matsui J., Kotliar D., Castro V., Akavia U.-D., Chen B.-J., Saucedo-Cuevas L., Rodriguez Barrueco R., Llobet-Navas D., et al. Integration of genomic data enables selective discovery of breast cancer drivers. Cell 2014, 159:1461-1475.
38. Schvartzman J.-M., Sotillo R., Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer 2010, 10:102-115.
39. Schvartzman J.-M., Duijf P.H.G., Sotillo R., Coker C., Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011, 19:701-714.
40. Sheltzer J.M., Blank H.M., Pfau S.J., Tange Y., George B.M., Humpton T.J., Brito I.L., Hiraoka Y., Niwa O., Amon A. Aneuploidy drives genomic instability in yeast. Science 2011, 333:1026-1030.
41. Silk A.D., Zasadil L.M., Holland A.J., Vitre B., Cleveland D.W., Weaver B.A. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc. Natl. Acad. Sci. USA 2013, 110:E4134-E4141.
42. Sotillo R., Hernando E., Díaz-Rodríguez E., Teruya-Feldstein J., Cordón-Cardo C., Lowe S.W., Benezra R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007, 11:9-23.
43. Sotillo R., Schvartzman J.-M., Socci N.D., Benezra R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010, 464:436-440.
44. Sottoriva A., Kang H., Ma Z., Graham T.A., Salomon M.P., Zhao J., Marjoram P., Siegmund K., Press M.F., Shibata D., Curtis C. A Big Bang model of human colorectal tumor growth. Nat. Genet. 2015, 47:209-216.
45. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., Nik-Zainal S., Martin S., Varela I., Bignell G.R., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404. Oslo Breast Cancer Consortium (OSBREAC).
46. Tamborero D., Gonzalez-Perez A., Perez-Llamas C., Deu-Pons J., Kandoth C., Reimand J., Lawrence M.S., Getz G., Bader G.D., Ding L., Lopez-Bigas N. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 2013, 3:2650.
47. Thompson S.L., Compton D.A. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 2010, 188:369-381.
48. Topham C., Tighe A., Ly P., Bennett A., Sloss O., Nelson L., Ridgway R.A., Huels D., Littler S., Schandl C., et al. MYC Is a Major Determinant of Mitotic Cell Fate. Cancer Cell 2015, 28:129-140.
49. Torres E.M., Sokolsky T., Tucker C.M., Chan L.Y., Boselli M., Dunham M.J., Amon A. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007, 317:916-924.
50. Valind A., Jin Y., Gisselsson D. Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution. PLoS ONE 2013, 8:e70445.
51. Zasadil L.M., Britigan E.M.C., Weaver B.A. 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin. Cell Dev. Biol. 2013, 24:370-379.
52. Zeng X., Shaikh F.Y., Harrison M.K., Adon A.M., Trimboli A.J., Carroll K.A., Sharma N., Timmers C., Chodosh L.A., Leone G., Saavedra H.I. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene 2010, 29:5103-5112.